Adenosine receptor antagonists and uses thereof

a technology of adenosine receptor and antagonist, which is applied in the field of compounds, can solve problems such as difficulty in formulating in a manner that provides reproducible plasma

Inactive Publication Date: 2022-02-24
TEON THERAPEUTICS INC
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent describes a new compound, calledFormula (A), and its various forms. The compound has certain characteristics that make it useful in various applications. The patent also describes methods for making the compound and its various forms. Overall, the patent provides a new compound and its various forms that can be used in various fields.

Problems solved by technology

Some A2B adenosine receptor antagonists are relatively insoluble in aqueous media and / or difficult to formulate using conventional pharmaceutical excipients, and thus can be difficult to formulate in a manner that provides reproducible plasma levels of the compound in mammals, in particular humans.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Adenosine receptor antagonists and uses thereof
  • Adenosine receptor antagonists and uses thereof
  • Adenosine receptor antagonists and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

of Exemplary Compound A

[0452]Compound A can be synthesized according to the scheme below.

[0453]Step 1. O-(chloromethyl)S-ethyl carbonothioate, sodium iodide and 18-crown-6 are dissolved in toluene and heated to about 100° C. for about 5 hours to yield S-ethyl O-(iodomethyl) carbonothioate. Step 2. n-Butyric acid and tetrabutyl ammonium bisulfate, sodium carbonate are added to a solution of chloro(chloromethoxy)methane in methylene chloride / water at room temperature and stirred overnight to afford solid (((ethylthio)carbonyl)oxy)methyl butyrate. Step 3.

[0454]Sulfuryl acid is added dropwise to a solution of (((ethylthio)carbonyl)oxy)methyl butyrate at about −30° C. The reaction mixture is allowed to warm to room temperature and stir for about 2 hours to yield a solution of ((chlorocarbonyl)oxy)methyl butyrate. Step 4. ((Chlorocarbonyl)oxy)methyl butyrate is added to a solution of compound 1 and sodium hydride in DMF at room temperature and allowed to stir for about 3 hours to yield Co...

example 2

of Exemplary Compound B

[0455]Compound B can be synthesized according the scheme below.

[0456]Step 1. O-(chloromethyl)S-ethyl carbonothioate, sodium iodide, and 18-crown-6 are dissolved in toluene and heated to 100° C. for 5 hours to form S-ethyl O-(iodomethyl) carbonothioate. Step 2. S-ethyl O-(iodomethyl) carbonothioate and dibenzyl hydrogen phosphate are reacted to form O-(((bis(benzyloxy)phosphoryl)oxy)methyl)S-ethyl carbonothioate. Step 3. Sulfuryl acid is added to a solution of O-(((bis(benzyloxy)phosphoryl)oxy)methyl)S-ethyl carbonothioate at −30° C. and allowed to warm to room temperature and stir for 2 hours to afford ((bis(benzyloxy)phosphoryl)oxy)methyl carbonochloridate. Step 4. To a DMF solution of ((bis(benzyloxy)phosphoryl)oxy)methyl carbonochloridate and compound 1 is added sodium hydride at room temperature. The solution is stirred for 3 hours. Pd / C in DMSO is added under H2 at room temperature, and the reaction mixture is allowed to stir for 5 hours to afford Compoun...

example 3

of Exemplary Compound C

[0457]Compound C was synthesized according to the steps below.

[0458]To a solution of compound 28 (50.0 g, 1650 mmol, 1.0 eq) and thionyl chloride (63.0 mL, 849.9 mmol, 0.5151 eq) was added zinc bromide (4.58 g, 19.99 mmol, 0.01212 eq) under nitrogen atmosphere. The resulting mixture was stirred at 80° C. for 24 h. The progress of the reaction mixture was monitored by 1H NMR. After completion of the reaction, the resulting mixture was isolated by distillation (b.p. 103-104° C.) to afford a mixture of slightly yellow oil and white solid. The mixture was filtered to afford compound 29 (51.645 g, 54%) as a slightly yellow oil.

[0459]To a solution of compound 29 (10.0 g, 87.72 mmol, 3.0 eq) in hexane (50 mL) was added sodium butyrate (3.2 g, 29.24 mmol, 1.0 eq) in a sealed tube. The resulting mixture was stirred at 80° C. for 16 h. The progress of the reaction mixture was monitored by 1H NMR. After completion of the reaction, the resulting mixture was filtered and t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

Disclosed herein are compounds, compositions, formulations, and methods for modulating the A2B adenosine receptor.

Description

CROSS-REFERENCE[0001]This application is a continuation of U.S. application Ser. No. 17 / 165,736, filed Feb. 2, 2021, which is a continuation of U.S. application Ser. No. 16 / 978,040, filed Sep. 3, 2020, which is a national stage application of PCT International Application PCT / US2019 / 020810, filed Mar. 5, 2019, which claims the benefit of U.S. Provisional Application No. 62 / 638,737, filed Mar. 5, 2018 and U.S. Provisional Application No. 62 / 688,088 filed Jun. 21, 2018, which are all incorporated herein by reference in their entireties.FIELD OF THE INVENTION[0002]Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of A2B adenosine receptor activity.BACKGROUND OF THE INVENTION[0003]Adenosine, an endogenous nucleoside, ubiquitously exists inside and outside of living cells. It pl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(United States)
IPC IPC(8): C07D473/06A61K9/08A61K9/20A61K9/48
CPCC07D473/06A61K9/4825A61K9/2054A61K9/08A61P9/00A61P1/16A61P11/00A61P13/12A61P25/00A61P3/04A61P3/10A61P35/00A61K9/4858C07F9/65616C07F9/6561
InventorLIU, JIWENELZEIN, ELFATIH
OwnerTEON THERAPEUTICS INC